Brief: Onesource Specialty Pharma Says USFDA Conducts Routine CGMP Inspection At Onesource SPD Bengaluru
02/07/2026 10:36
BRIEF-Onesource Specialty Pharma Says USFDA Conducts Routine CGMP Inspection At Onesource SPD Bengaluru July 2 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS:
ONESOURCE SPECIALTY PHARMA - USFDA CONDUCTS ROUTINE CGMP INSPECTION AT ONESOURCE SPD BENGALURU JUNE 22-30, 2026
ONESOURCE SPECIALTY PHARMA - INSPECTION CONCLUDES WITH ONE OBSERVATION
Source text: ID:nBSE1kvcNJ
Further company coverage: ONEO.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Onesource Specialty Pharma
See all newsIndia's Onesource Specialty Pharma rises most in 2-1/2 months on quarterly profit
Brief: Onesource Specialty Pharma June-Quarter Consol PAT 250 Million Rupees
Brief: Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
Brief: Onesource Specialty Pharma Says Delay In Dr Reddy's Supplies Does Not Materially Impact Co's Operations
Brief: Onesource Specialty Pharma Says USFDA Conducts Routine CGMP Inspection At Onesource SPD Bengaluru